Work

Randomized, parallel arm, phase II study of telotristat (Xermelo) in combination with lutetium Lu 177 dotatate (Lutathera) in well-differentiated neuroendocrine tumors (NETs).

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.4_suppl.tps516

Authors: Aman Chauhan, Charles Kunos, Donglin Yan, Aman Khurana, Riham Khouli, Michael J. Cavnar, Prakash Pandalai, Joseph Kim, Lowell Brian Anthony

Institutions: University of Kentucky, Markey Cancer Center, Stony Brook University

Language: English

Topic: Neuroendocrine Tumor Research Advances

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4206380271

Cites:

Cited by: 1

Related to: 10